LENSAR, Inc. Common Stock vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| LNSR | RMD | |
|---|---|---|
| Market Cap | $103.69 million | $32.95 billion |
| Revenue (TTM) | $60.26 million | $5.65 billion |
| Net Income (TTM) | $34.70 million | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| LNSR | RMD | |
|---|---|---|
| P/E Ratio | — | 22.20 |
| Price / Book | 6.96 | 5.00 |
| Price / Sales | 1.72 | 5.83 |
LNSR and RMD split the valuation factors evenly.
Profitability
| LNSR | RMD | |
|---|---|---|
| Net Margin | 57.57% | 26.94% |
| Return on Equity | 232.78% | 23.13% |
LNSR leads on 2 of 2 profitability factors.
Dividend
| LNSR | RMD | |
|---|---|---|
| Dividend Yield | — | 1.14% |
| Payout Ratio | — | 25.31 |
LNSR and RMD split the dividend factors evenly.
Risk & Sentiment
| LNSR | RMD | |
|---|---|---|
| Short Interest | 5.49% | 4.02% |
RMD leads on 1 of 1 risk & sentiment factors.
Dig deeper: LNSR overview, LNSR financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.